Form 4: Centene Director James Dallas Receives Stock Award

Centene Corporation Director James Dallas acquired 3,992 restricted stock units as part of an equity compensation award.

Summary

• Director James Dallas was granted 3,992 restricted stock units (RSUs) on May 12, 2026.
• The RSUs are scheduled to vest in full on May 12, 2027, or upon the date of the next annual meeting of stockholders, whichever occurs first.
• Following this transaction, Mr. Dallas holds 47,874.185 shares directly and maintains an indirect interest in 1,693 shares held by a revocable family trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• The grant aligns the director's interests with those of shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The restricted stock units are set to vest on May 12, 2027, or the date of the next annual meeting of stockholders.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practice to ensure long-term alignment between directors and shareholders in the healthcare managed care sector.

Comparison to Industry Standards

• The grant of restricted stock units to non-employee directors is consistent with standard compensation practices for S&P 500 companies.
• The vesting schedule of one year is typical for annual director equity awards.

Related Party Transactions

• The reporting person maintains an indirect interest in 1,693 shares held by a revocable family trust where he serves as a co-trustee.

Stakeholder Impact

• Minimal impact; the transaction represents standard director compensation.

Next Steps

• Vesting of the 3,992 restricted stock units on May 12, 2027, or the next annual meeting.

Key Dates

Keywords

Centene, CNC, Form 4, Insider Trading, Director Compensation, Equity Grant